Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Remission in rheumatoid arthritis.

F Wolfe, D J Hawley

    The Journal of Rheumatology
    |April 1, 1985
    PubMed
    Summary

    Remission rates in rheumatoid arthritis were 18.8% by chart review and 18.1% using American Rheumatism Association (ARA) criteria. Remission duration averaged 10 months, influenced by therapy and patient factors.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Looking at Fibromyalgia differently - the meaning and consequences of fibromyalgia as a dimensional disorder.

    Seminars in arthritis and rheumatism·2023
    Same author

    Fibromyalgia criteria in a tertiary pain clinic.

    Scandinavian journal of rheumatology·2015
    Same author

    Convergence between the 1990 and 2010 ACR diagnostic criteria and validation of the Spanish version of the Fibromyalgia Survey Questionnaire (FSQ).

    Rheumatology international·2014
    Same author

    Increased incidence of herpes zoster among patients with systemic lupus erythematosus.

    Lupus·2012
    Same author

    Longitudinal patterns of analgesic and central acting drug use and associated effectiveness in fibromyalgia.

    European journal of pain (London, England)·2012
    Same author

    Diagnosis and diagnostic tests for fibromyalgia (syndrome).

    Reumatismo·2012

    Area of Science:

    • Rheumatology
    • Clinical Epidemiology
    • Disease Monitoring

    Background:

    • Rheumatoid arthritis (RA) management requires clear remission definitions.
    • Assessing remission in RA patients is crucial for treatment evaluation.
    • Prospective data collection aids in understanding disease trajectories.

    Purpose of the Study:

    • To evaluate remission rates in rheumatoid arthritis patients.
    • To assess the effectiveness of remission criteria in a clinical setting.
    • To identify factors associated with achieving and maintaining remission.

    Main Methods:

    • Analysis of prospectively collected data from 458 RA patients.
    • Application of American Rheumatism Association (ARA) criteria and modified chart review for remission assessment.
    • Calculation of remission rates, duration, and association with therapies and patient characteristics.

    Main Results:

    • Remission observed in 18.8% of patients by chart review and 18.1% by ARA criteria.
    • Remission occupied 34.5% of follow-up duration for achieving patients, with a median length of 10 months.
    • Gold and penicillamine therapies showed remission rates of 18.6% and 16.7% respectively; 13.6% of untreated patients also achieved remission.
    • The ARA Preliminary Criteria demonstrated 80.2% sensitivity and 96.2% specificity.
    • Female sex, disease onset before 60, and early erosions were linked to lower remission rates in treated patients.

    Conclusions:

    • Remission rates in RA are modest, with variations based on assessment criteria.
    • The ARA Preliminary Criteria are highly specific and sensitive for RA remission.
    • Patient demographics and disease characteristics influence remission achievement, even with therapy.

    Related Experiment Videos